IEX vs KZR · P/E 29, rev $1.81B vs $53.9M cap
IDEX Corporation (IEX) versus Kezar Life Sciences Inc (KZR) — a side-by-side from cached financials, not a winner call.
IDEX Corporation (IEX) is a specialty industrial machinery company listed on US.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported IEX revenue for 2026-06-30 was $1.81B. Net income was $263.4M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
IEX currently screens at market cap $13.71B and trailing P/E 28.8. KZR currently screens at market cap $53.9M.
Not investment advice. Open the IEX and KZR stock pages for the full models.
Not investment advice.